Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for detecting lupus anticoagulants

A lupus anticoagulant, detection method technology, applied in biochemical equipment and methods, microbial determination/inspection, biological testing, etc., to achieve the effect of eliminating the difference between batches

Active Publication Date: 2014-03-19
SCHOOL JURIDICAL PERSON HIGASHI NIPPON GAKUEN +1
View PDF4 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore, these LA detection methods are seldom used alone, and it is recommended to combine two or more inspections and judge the results comprehensively (Non-Patent Document 3)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for detecting lupus anticoagulants
  • Method for detecting lupus anticoagulants
  • Method for detecting lupus anticoagulants

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0040] The present invention is further described in detail through the following examples, but the present invention is not limited to the following examples.

[0041]

[0042] (1) APTT screening test

[0043] Measurement was performed using PTT LA reagent "RD" (manufactured by DIAGNOSTICA STAGO) and an automatic blood coagulation analyzer STA-R (manufactured by Roche Diagnostics). For the cutoff value used for determination, a value obtained by measuring the value of 20 or more healthy subjects + 2SD was used.

[0044] (2) dRVVT test

[0045] The LA test "Gradipore" (manufactured by the Institute of Medical Biology) was used, and the blood coagulation automatic analyzer STA-R was used for measurement. For the cutoff value used for determination, a value obtained by measuring the value of 20 or more healthy subjects + 2SD was used.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Provided is a simple method for detecting lupus anticoagulants without using blood plasma from healthy individuals, which is capable of distinguishing between blood-coagulation-factor deficiencies, even in blood samples originating from patients undergoing anticoagulant therapies using warfarin, heparin, or the like, without being affected by said anticoagulant therapies. The method for detecting the lupus anticoagulants is characterized in that it involves the following three steps, (A), (B) and (C): (A) a step in which a buffering solution composition containing blood coagulation factors is added to a blood sample and to a diluted sample of said blood sample both before and during the measurement of the blood coagulation time; (B) a step in which the blood coagulation time is measured for each of the samples from step (A); and (C) a step in which the blood coagulation times of each of the samples obtained in step (B) are compared.

Description

technical field [0001] The invention relates to a method for detecting positive lupus anticoagulant used in the diagnosis of antiphospholipid antibody syndrome. Background technique [0002] Lupus anticoagulant (LA) is the first reported circulating anticoagulant in patients with SLE (Systemic Lupus Erythematosus). For LA-positive patients, little bleeding tendency was clinically recognized, but a thrombus tendency was shown. However, samples derived from LA-positive patients showed a tendency to prolong activated partial thromboplastin time (APTT) and prothrombin time (PT) in vitro. According to subsequent studies, it was clarified that LA is an autoantibody against a complex of negatively charged phospholipids and proteins in the blood such as β2-glycoprotein I (β2GPI) or prothrombin, and it is now known that LA is an autoantibody against diseases other than SLE. The disease also mostly detects LA. In particular, the occurrence frequency is high in the pathology collect...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G01N33/86
CPCC12Q1/56G01N2800/104G01N33/86G01N33/564G01N2800/24
Inventor 家子正裕森川千鹤
Owner SCHOOL JURIDICAL PERSON HIGASHI NIPPON GAKUEN
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com